Strota / ZYDUSLIFE / Quarterly results

Zydus Lifesciences Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Zydus Lifesciences' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹8,017 crore (+22.0% year on year), net profit ₹940 crore (-35.9% year on year), EPS ₹9.35. Announced 11 Aug 2026, 7:24 pm IST. The shares rose 1.18% on 12 Aug 2026, 1.32 points better than the Nifty 50. Next results board meeting: 4 Nov 2026.
Revenue
₹8,017 cr
YoY +22.0% · QoQ +5.7%
Net profit
₹940 cr
YoY -35.9% · QoQ -26.1%
EPS (basic)
₹9.35
YoY -35.9%
Share price reaction
+1.2%
12 Aug 2026 · vs Nifty +1.3%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹6,528 cr Q4 FY25 net profit: ₹72.80 cr Q4 FY25 Q1 FY26 Revenue: ₹6,574 cr Q1 FY26 net profit: ₹1,467 cr Q1 FY26 Q2 FY26 Revenue: ₹6,123 cr Q2 FY26 net profit: ₹1,259 cr Q2 FY26 Q3 FY26 Revenue: ₹6,864 cr Q3 FY26 net profit: ₹1,042 cr Q3 FY26 Q4 FY26 Revenue: ₹7,587 cr Q4 FY26 net profit: ₹1,272 cr Q4 FY26 Q1 FY27 Revenue: ₹8,017 cr Q1 FY27 net profit: ₹940 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2711 Aug 2026, 7:24 pm IST 8,017+22.0%940-35.9% 11.7%9.35 +1.2%
Q4 FY2619 May 2026, 7:01 pm IST 7,587+16.2%1,272+1647.9% 16.8%12.65 +2.1%
Q3 FY269 Feb 2026, 4:50 pm IST 6,864—1,042— 15.2%10.36 -3.9%
Q2 FY266 Nov 2025, 6:19 pm IST 6,123—1,259— 20.6%12.51 +0.8%
Q1 FY2612 Aug 2025, 5:00 pm IST 6,574—1,467— 22.3%14.58 +3.5%
Q4 FY2520 May 2025, 6:42 pm IST 6,528—72.80— 1.1%11.64 +0.7%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How ZYDUSLIFE shares react to results

Across the last 6 results here, the shares rose on 5 and fell on 1. The average move was +0.73%, and the average size of the move either way 2.03%; the biggest was -3.91% after the Q3 FY26 results. In the 1 quarters where profit grew year on year, the shares rose once.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Zydus Lifesciences' Q1 FY27 results?

For the quarter to 30 Jun 2026, Zydus Lifesciences reported revenue of ₹8,017 crore (+22.0% year on year) and net profit of ₹940 crore (-35.9%), with basic EPS of ₹9.35.

How did Zydus Lifesciences shares react to the Q1 results?

They rose 1.18% on 12 Aug 2026, the first session that could trade on the results (announced after the close); that was 1.32 points better than the Nifty 50 that day.

When is Zydus Lifesciences' next results date?

The board meets on 4 Nov 2026 to consider results, according to the company's intimation to NSE.

Do Zydus Lifesciences shares usually rise after results?

In the last 6 results here they rose 5 times and fell 1 times, moving 2.03% on average either way.

About this data

From Zydus Lifesciences' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See ZYDUSLIFE stock page for price, open interest and deals, all results declared this week and the results calendar, and ZYDUSLIFE dividend history.